Regulatory Expertise SUNRx has deep experience in 340B program management since 2006, highlighting a strong regulatory compliance capability that can be leveraged to upsell governance, audit support, and compliance advisory services to hospitals expanding or optimizing 340B implementations.

Acquisition Momentum Recent acquisition of AuthorityRx in 2023 indicates a growth strategy to broaden 340B savings capabilities and referrals capture, suggesting a sales opportunity for enhanced integration services, advanced analytics, and expanded contract pharmacy network solutions.

Cloud and Data Stack SUNRx utilizes modern technologies including Snowflake, Power BI, Salesforce, and Azure, signaling readiness for data-driven program optimization; sales opportunities exist for advanced analytics, dashboards, BI integrations, and data migration or modernization projects.

SMB Focus with Growth Potential With a 51-200 employee footprint and mid-market revenue range, SUNRx sits between smaller peers and larger enterprise competitors, representing a target for scalable 340B management platforms, managed services, and modular add-ons as hospitals seek cost containment and compliance efficiency.

Industry Collaboration Active participation in 340B regulatory briefings and partnerships (MHA Endorsed Partner) indicates openness to strategic engagements, webinars, and co-marketing opportunities that can accelerate pipeline through joint events, case studies, and reference selling.